Fig. 3
From: PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA
PHF5A was essential for in vivo tumor formation. (A) Tumor volume was calculated based on tumor size measured at indicated time intervals from 13 to 27 days post injection. (B) In vivo imaging was performed to evaluate tumor formation. (C) After sacrificing mice, xenograft was removed, weighted and photographed for tumor size and weight. (D) Immunostaining of Ki-67 was used to analyze the proliferative ability influenced by PHF5A (Magnification 200× and 400×). ***p < 0.001